➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKinsey
Medtronic
McKesson
Harvard Business School

Last Updated: June 5, 2020

DrugPatentWatch Database Preview

Cyanocobalamin - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for cyanocobalamin and what is the scope of patent protection?

Cyanocobalamin is the generic ingredient in fifteen branded drugs marketed by Par Pharm, Pharmacia And Upjohn, Lilly, Watson Labs, Abraxis Pharm, Akorn, Am Regent, Dell Labs, Dr Reddys, Fresenius Kabi Usa, Luitpold, Lyphomed, Mylan Institutional, Mylan Labs Ltd, Sanofi Aventis Us, Solopak, Somerset Theraps Llc, Vitruvias Therap, Warner Chilcott, West-ward Pharms Int, Wyeth Ayerst, Accord Hlthcare, Merck, Bel Mar, Bristol Myers Squibb, Savage Labs, Bayer Hlthcare, Endo Pharms Inc, West Ward, Ge Healthcare, and Armour Pharm, and is included in thirty-five NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for cyanocobalamin. Twelve suppliers are listed for this compound.

Drug Prices for cyanocobalamin

See drug prices for cyanocobalamin

Drug Sales Revenue Trends for cyanocobalamin

See drug sales revenues for cyanocobalamin

Recent Clinical Trials for cyanocobalamin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Tanta UniversityPhase 3
IMSS Hospital General de Zona 11, Piedras NegrasPhase 3
University of Southern CaliforniaEarly Phase 1

See all cyanocobalamin clinical trials

Recent Litigation for cyanocobalamin

Identify potential future generic entrants

District Court Litigation
Case NameDate
ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA2018-06-22
Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA2017-07-28
Endo Pharmaceuticals Inc. v. Perrigo UK FINCO Limited Partnership

See all cyanocobalamin litigation

Pharmacology for cyanocobalamin
Drug ClassVitamin B12
Synonyms for cyanocobalamin
1H-Benzimidazole,6-dimethyl-1-(3-O-phosphono-.alpha.-D-ribofuranosyl)-, monoester with cobinamide cyanide hydroxide, inner salt
3-[tris(2-amino-2-oxo-ethyl)-bis(3-amino-3-oxo-propyl)-cyano-dihydroxy-(hydroxymethyl)-undecamethyl-dioxo-[?]yl]propanamide
68-19-9
AB01568252_01
AB2000361
AKOS015894306
Anacobin
AS-13159
BDBM83973
Berubigen
Betalin 12, crystalline
Betaline-12
Betolvex
Bevidox
Bevidox concentrate
Biocobalamine
Byladoce
C02823
C63H88CoN14O14P
Cabadon M
CAS-68-19-9
CCG-220433
CHEBI:15982
CHEBI:17439
cid_25102581
CN-Cbl
Coalpha-[alpha-(5,6-dimethylbenzimidazolyl)]-Cobeta-cyanocobamide
cob(I)alamin
Cobadoce forte
cobalamin
Cobalamin;vitamin B-12;Cyanocobalamin
Cobalin
Cobamide,6-dimethyl-1H-benzimidazole-
Cobamide,6-dimethyl-1H-benzimidazolyl-, cyanide
Cobavite
Cobinamide, dihydrogen phosphate
Cobinamide, dihydrogen phosphate (ester), inner salt, 3'-ester with 5,6-dimethyl-1-.alpha.-D-ribofuranosylbenzimidazole
Cobinamide,6-dimethyl-1-.alpha.-D-ribofuranosylbenzimidazole, inner salt
Cobinamide,dihydrogenphosphate(ester),inner salt,3'-ester with(5,6-Dimethyl-1-a-d-ribofuranosyl-1H-benzimidazole-kn3),ion(1+)(9ci)
component of Endoglobin
component of Vitron-C-Plus
Copharvit 5000
Covit
Crystamin
Crystamine
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
Cyanocobalamin (JP15/USP)
Cyanocobalamin (JP17/USP/INN)
Cyanocobalamin (Vitamin B12)
Cyanocobalamin (Vitamin B12) 1.0 mg/ml in Methanol
Cyanocobalamin;Cyanocob(III)alamin
Cyanocobalamine
Cyanocobalmin
cyanoject
Cyanokobalamin
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyomin (TN)
Cyredin
Cytacon
Cytamen
Cytobion
D00166
DB00115
Depinar
Dicopac
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
DSSTox_CID_24346
DSSTox_GSID_44346
DSSTox_RID_80159
DTXSID7044346
Ducobee
Duodecibin
Embiol
Emociclina
Eritrone
Erycytol
Erythrotin
Euhaemon
Extrinsic factor
Factor II
FDJOLVPMNUYSCM-WZHZPDAFSA-L
Fermin
Fresmin
H486
Hemomin
Hepagon
Hepavis
Hepcovite
HMS1569G08
HMS2096G08
HMS2232I12
HMS3713G08
Hydrido-Cobalamin
Hydridocobalamin
hydrobexan
Hylugel plus
Lactobacillus lactis dorner factor
Macrabin
Mecobalamin
Megalovel
MFCD00151092 (98%)
Milbedoce
Millevit
MLS002153809
Nagravon
Nascobal (TN)
NCGC00016302-01
NCGC00249888-01
Normocytin
Novidroxin
NSC-80365
NSC80365
P6YC3EG204
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Prestwick_564
Q252251
Q55167869
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
Rubramin PC (TN)
Rubripca
Rubrocitol
s1902
SMR001233181
SRI 2215
SY010769
Sytobex
Tox21_110358
Tox21_113664
UNII-P6YC3EG204
V0344
Vibalt
Vibisone
Virubra
Vita-rubra
vitamin B-12
vitamin B-12s
vitamin B12
Vitamin B12 (charged)
Vitamin B12 complex
Vitamin B12 NOS
Vitamin B12 preparation
Vitamin B12b
vitamin B12s
Vitamin-B12
Vitamine B12
Vitarubin
Vitral
WLN: D C5656 B-5 B6 B5 S5 J&5 B-19- Q&6 N&5/B-N/DU/J&-M& J&- O& 9ABBBBCSTT V& AN-CO-&& B-N CN TN C&
Paragraph IV (Patent) Challenges for CYANOCOBALAMIN
Tradename Dosage Ingredient NDA Submissiondate
NASCOBAL SPRAY, METERED;NASAL cyanocobalamin 021642 2017-04-28

US Patents and Regulatory Information for cyanocobalamin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080557-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Dr Reddys CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 080573-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Lyphomed CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 083075-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Vitruvias Therap CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 209255-001 Dec 18, 2018 AP RX No No   Start Trial   Start Trial   Start Trial
Bel Mar RUBIVITE cyanocobalamin INJECTABLE;INJECTION 010791-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd CYANOCOBALAMIN cyanocobalamin INJECTABLE;INJECTION 204829-001 Jun 5, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
McKinsey
Medtronic
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.